Literature DB >> 19860845

CD24-dependent MAPK pathway activation is required for colorectal cancer cell proliferation.

Weifei Wang1, Xinying Wang, Liang Peng, Qiliang Deng, Yan Liang, Haitao Qing, Bo Jiang.   

Abstract

CD24 is a glycosylphosphatidylinositol-anchored membrane protein reported to be overexpressed in human tumorigenesis and progression. Our purpose was to determine the role of CD24 in the proliferation of colorectal cancer cells and the potential mechanisms in this process. Our data showed that CD24 promoted cell growth and induced activation of extracellular signal-regulated kinases, Raf-1, and p38 mitogen-activated protein kinase. Furthermore, suppression of extracellular signal-regulated kinases and p38 mitogen-activated protein kinase activity by their specific inhibitors, U0126 and SB203580, abrogated CD24-induced proliferation in vitro. By tumorigenicity assay in female BALB/c nude mice, we further demonstrated that CD24 promoted tumor growth in vivo. Immunohistochemical analysis revealed that CD24 expression occurred in 92.5% of human colorectal cancer tissue, and increased with tumor progression. More importantly, the stainings of phospho-extracellular signal-regulated kinases and phospho-p38 mitogen-activated protein kinase were strongly correlated with CD24 expression. Taken together, our data suggest that CD24-dependent extracellular signal-regulated kinases and p38 mitogen-activated protein kinase activations are required for colorectal cancer cell proliferation in vitro and in vivo. The linkage of CD24 and the mitogen-activated protein kinase pathway may unravel a novel mechanism in the regulation of colorectal cancer proliferation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19860845     DOI: 10.1111/j.1349-7006.2009.01370.x

Source DB:  PubMed          Journal:  Cancer Sci        ISSN: 1347-9032            Impact factor:   6.716


  26 in total

1.  CD24 promotes tumor cell invasion by suppressing tissue factor pathway inhibitor-2 (TFPI-2) in a c-Src-dependent fashion.

Authors:  Niko Bretz; Aurelia Noske; Sascha Keller; Natalie Erbe-Hofmann; Thomas Schlange; Alexei V Salnikov; Gerd Moldenhauer; Glen Kristiansen; Peter Altevogt
Journal:  Clin Exp Metastasis       Date:  2011-10-08       Impact factor: 5.150

2.  The CD24 protein inducible expression system is an ideal tool to explore the potential of CD24 as an oncogene and a target for immunotherapy in vitro and in vivo.

Authors:  Shiran Shapira; Dina Kazanov; Samuel Weisblatt; Alex Starr; Nadir Arber; Sarah Kraus
Journal:  J Biol Chem       Date:  2011-10-05       Impact factor: 5.157

3.  CD24 controls Src/STAT3 activity in human tumors.

Authors:  Niko P Bretz; Alexei V Salnikov; Claudia Perne; Sascha Keller; Xiaoli Wang; Claudia T Mierke; Mina Fogel; Natalie Erbe-Hofmann; Thomas Schlange; Gerhard Moldenhauer; Peter Altevogt
Journal:  Cell Mol Life Sci       Date:  2012-07-04       Impact factor: 9.261

4.  Elevated hippocampal CD24 in astrocytes participates in neural regeneration possibly via activating SHP2/ERK pathway after experimental traumatic brain injury in mice.

Authors:  Xuan Gao; Han Wang; Yong-Yue Gao; Xiao-Ming Zhou; Tao Tao; Guang-Jie Liu; Yan Zhou; Wei Li; Chun-Hua Hang
Journal:  Am J Transl Res       Date:  2020-10-15       Impact factor: 4.060

5.  Effects of radix curcumae-derived diterpenoid C on Helicobacter pylori-induced inflammation and nuclear factor kappa B signal pathways.

Authors:  Xuan Huang; Bin Lv; Shuo Zhang; Qun Dai; Bing-Bing Chen; Li-Na Meng
Journal:  World J Gastroenterol       Date:  2013-08-21       Impact factor: 5.742

6.  CD24 is an effector of HIF-1-driven primary tumor growth and metastasis.

Authors:  Shibu Thomas; Michael A Harding; Steven C Smith; Jonathan B Overdevest; Matthew D Nitz; Henry F Frierson; Scott A Tomlins; Glen Kristiansen; Dan Theodorescu
Journal:  Cancer Res       Date:  2012-08-27       Impact factor: 12.701

7.  CD24 can be used to isolate Lgr5+ putative colonic epithelial stem cells in mice.

Authors:  Jeffrey B King; Richard J von Furstenberg; Brian J Smith; Kirk K McNaughton; Joseph A Galanko; Susan J Henning
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-06-21       Impact factor: 4.052

8.  Lyn is involved in CD24-induced ERK1/2 activation in colorectal cancer.

Authors:  Ning Su; Liang Peng; Bingqing Xia; Yingying Zhao; Angao Xu; Jing Wang; Xinying Wang; Bo Jiang
Journal:  Mol Cancer       Date:  2012-06-26       Impact factor: 27.401

Review 9.  Polyphenols and human health: prevention of disease and mechanisms of action.

Authors:  David Vauzour; Ana Rodriguez-Mateos; Giulia Corona; Maria Jose Oruna-Concha; Jeremy P E Spencer
Journal:  Nutrients       Date:  2010-11-08       Impact factor: 5.717

10.  Antibody targeting of CD24 efficiently retards growth and influences cytokine milieu in experimental carcinomas.

Authors:  A V Salnikov; N P Bretz; C Perne; J Hazin; S Keller; M Fogel; I Herr; T Schlange; G Moldenhauer; P Altevogt
Journal:  Br J Cancer       Date:  2013-03-19       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.